Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A Phase 1/2 Single-Arm, Open-Label Study to Evaluate the Safety and Efficacy of Brentuximab Vedotin in Combination with Bendamustine for Patients with Hodgkin Lymphoma in the First Salvage Setting: Interim Results LaCasce, A., Sawas, A., Bociek, R., Ansell, S., Vose, J., O'Meara, M., Advani, R. ELSEVIER SCIENCE INC. 2014: S161
View details for DOI 10.1016/j.bbmt.2013.12.257
View details for Web of Science ID 000331155400235